The total pancreatic cancer market size is expected to increase in the 7MM during the forecast period, driven by ongoing ...
Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...
Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor ...
IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 12:30 PM ESTCompany ParticipantsShaun Bagai - ...
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...
Researchers at the Cancer Center and Research Institute (CCRI) at the University of Mississippi Medical Center (UMMC) are ...
Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical ...
1d
Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine ...
Statistics show a clear spike in eight cancers in younger people, but that has brought a debate over whether many cases ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback